Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBD Daily is a commercial CBD-infused personal care and wellness brand focused on topical skin, body, and haircare products rather than prescription therapeutics. The brand is manufactured and marketed by Earthly Body, a family-owned California company that has produced hemp-based personal care products since 1996 and launched CBD Daily after California legalized recreational marijuana in 2016. Its portfolio includes CBD creams, sprays, serums, massage lotions, candles, shampoo, and conditioner, sold direct-to-consumer and through wholesale retail channels. Products are positioned around comfort, moisturization, and wellness, with third-party testing, vegan and cruelty-free claims, and no FDA-approved disease-treatment claims. For a biotech analyst, this is best understood as a consumer cannabinoid topical brand in the broader health and wellness market, not a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBD Daily.